Krishna Institute of Medical Sciences (KIMS) in Hyderabad, India, has placed an order worth $40m with Elekta, a precision radiation therapy solutions provider.

The order includes a comprehensive suite of advanced hardware and software.

These include Elekta Unity MR-Linacs, Esprit (Elekta’s latest Leksell Gamma Knife) systems, Elekta One suite of oncology software solutions, Versa HD linear accelerators, and Flexitron brachytherapy afterloaders.

KIMS Hospitals chairman and managing director Dr Bhaskar Rao Bollineni said: “We are delighted to partner with Elekta to bring these cutting-edge technologies to our patients.

“These devices and software will enable us to provide more personalised and precise treatments for various types of cancers while minimising side effects and improving quality of life.

“We are committed to offering the best possible care to our patients and investing in innovation that can make a difference.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

This contract is expected to benefit thousands of cancer patients in India, where around 1.3 million people were diagnosed with the disease in 2020.

Founded in 2000, KIMS Hyderabad runs 12 facilities in Telangana, Andhra Pradesh, and Maharashtra.

The equipment will be deployed in a phased manner over three years across the hospital chain’s facilities, with the first deployment planned in the fourth quarter of fiscal 2024.

Elekta CEO Gustaf Salford said: “We are proud to collaborate with KIMS Hyderabad, one of the leading healthcare providers in India, to deliver our state-of-the-art radiation therapy solutions.

“We believe that these devices will enhance the clinical capabilities and outcomes of their hospitals and benefit thousands of cancer patients.

“I look forward to a long-term partnership with KIMS Hyderabad and supporting their vision of providing world-class cancer care.”

Based in Stockholm, Sweden, Elekta works on advancing cancer care. It has offices in over 40 countries and a workforce of 4,500 people.